Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FPX5T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,643
Award facts
- Contract value 100% obligated
- $19,643.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,643.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on February 4, 2026, with completion scheduled for February 5, 2026. The award was made on a non-set-aside, competitive basis and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order execution under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical vendor in the federal pharmaceutical supply chain, providing an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to the Department of Defense and other federal healthcare systems. The parent company Cencora, Inc. (formerly doing business as AmerisourceBergen) is a major pharmaceutical distributor registered in the System for Award Management and competes on a full and open basis for federal contracts. This particular order for Zepbound, a diabetes and weight management medication, aligns with the contractor's demonstrated capability to fulfill government requirements for specialty pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FPX5T?
SPE2DR26FPX5T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FPX5T worth?
The government has obligated $19,643 on SPE2DR26FPX5T.
Is contract SPE2DR26FPX5T an order under another contract?
Yes. SPE2DR26FPX5T is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPX5T competed?
The extent of competition for SPE2DR26FPX5T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award